Cutera (NASDAQ:CUTR) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Cutera (NASDAQ:CUTR) in a research report released on Wednesday. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Stock Down 3.7 %

NASDAQ:CUTR opened at $0.41 on Wednesday. The stock has a market cap of $8.36 million, a P/E ratio of -0.06 and a beta of 1.31. The business’s 50-day moving average price is $0.41 and its two-hundred day moving average price is $0.68. Cutera has a twelve month low of $0.28 and a twelve month high of $3.10.

Cutera (NASDAQ:CUTR) last announced its earnings results on Thursday, November 7th. The medical device company reported ($1.94) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.96) by ($0.98). The company had revenue of $32.50 million for the quarter, compared to analyst estimates of $32.57 million. During the same quarter in the prior year, the company earned ($2.22) earnings per share. On average, equities research analysts expect that Cutera will post -5.78 EPS for the current fiscal year.

Institutional Investors Weigh In On Cutera

A hedge fund recently raised its stake in Cutera stock. Squarepoint Ops LLC grew its holdings in shares of Cutera, Inc. (NASDAQ:CUTR) by 164.5% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 113,964 shares of the medical device company’s stock after acquiring an additional 70,870 shares during the quarter. Squarepoint Ops LLC owned 0.57% of Cutera worth $172,000 at the end of the most recent quarter. 90.70% of the stock is owned by hedge funds and other institutional investors.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.